Therapeutic Interventions in Adult Low-Grade Gliomas

키워드

참고문헌 (50)

1. Louis DN, "The 2016 World Health Organization classification of tumors of the central nervous system : a summary", Acta Neuropathol, 131, pp.803~820 (2016)
2. Cancer Genome Atlas Research Network, "Comprehensive, integrative genomic analysis of diffuse lower-grade gliomas", N Engl J Med, 372, pp.2481~2498 (2015)
3. Ostrom QT, "CBTRUS statistical report: primary brain and central nervous system tumors diagnosed in the United States in 2008-2012", Neuro Oncol, 17(Suppl 4), pp.iv1~iv62 (2015)
4. Shaw E, "Prospective randomized trial of low-versus high-dose radiation therapy in adults with supratentorial low-grade glioma : initial report of a North Central Cancer Treatment Group", Radiation Therapy Oncology Group, J Clin Oncol, pp.2002, 20[DOI]
5. Bogdańska MU, "A mathematical model describes the malignant transformation of low grade gliomas : prognostic implications", PLoS One, 12, pp.e0179999~ (2017)
6. Schiff D, "Low-grade gliomas", Continuum(Minneap Minn), 21, pp.345~354 (2015)
7. Capelle L, "Spontaneous and therapeutic prognostic factors in adult hemispheric World Health Organization grade II gliomas : a series of 1097 cases : clinical article", J Neurosurg, 118, pp.1157~1168 (2013)
8. Smith JS, "Role of extent of resection in the long-term outcome of low-grade hemispheric gliomas", J Clin Oncol, 26, pp.1338~1345 (2008)
9. McGirt MJ, "Extent of surgical resection is independently associated with survival in patients with hemispheric infiltrating low-grade gliomas", Neurosurgery, 63, pp.700~708 (2008)
10. Cordier D, "A better surgical resectability of WHO grade II gliomas is independent of favorable molecular markers", J Neurooncol, 121, pp.185~193 (2015)
11. Wijnenga MM, "The impact of surgery in molecularly defined low-grade glioma : an integrated clinical, radiological, and molecular analysis", Neuro Oncol, 20, pp.103~112 (2018)
12. Nimsky C, "Volumetric assessment of glioma removal by intraoperative high-field magnetic resonance imaging", Neurosurgery, 55, pp.358~370 (2004)[DOI]
13. Claus EB, "Survival rates in patients with low-grade glioma after intraoperative magnetic resonance image guidance", Cancer, 103, pp.1227~1233 (2005)
14. Duffau H, "Is non-awake surgery for supratentorial adult low-grade glioma treatment still feasible", Neurosurg Rev, 41, pp.133~139 (2018)
15. Duffau H, "Mapping the connectome in awake surgery for gliomas : an update", J Neurosurg Sci, 61, pp.612~630 (2017)
16. Shaw EG, "Recurrence following neurosurgeon-determined gross-total resection of adult supratentorial low-grade glioma : results of a prospective clinical trial", J Neurosurg, 109, pp.835~841 (2008)
17. van den Bent MJ, "Long-term efficacy of early versus delayed radiotherapy for low-grade astrocytoma and oligodendroglioma in adults : the EORTC 22845 randomised trial", Lancet, 366, pp.985~990 (2005)
18. Oberheim Bush NA, "Treatment strategies for low-grade glioma in adults", J Oncol Pract, 12, pp.1235~1241 (2016)
19. Karim AB, "A randomized trial on dose-response in radiation therapy of lowgrade cerebral glioma : European Organization for Research and Treatment of Cancer(EORTC)Study 22844", Int J Radiat Oncol Biol Phys, 36, pp.549~556 (1996)
20. Karim AB, "Randomized trial on the efficacy of radiotherapy for cerebral lowgrade glioma in the adult : European Organization for Research and Treatment of Cancer Study 22845 with the Medical Research Council study BRO4 : an interim analysis", Int J Radiat Oncol Biol Phys, 52, pp.316~324 (2002)
21. Brown PD, "Effects of radiotherapy on cognitive function in patients with low-grade glioma measured by the folstein mini-mental state examination", J Clin Oncol, 21, pp.2519~2524 (2003)
22. Surma-aho O, "Adverse long-term effects of brain radiotherapy in adult lowgrade glioma patients", Neurology, 56, pp.1285~1290 (2001)
23. Baumert BG, "Is there a place for radiotherapy in low-grade gliomas", Adv Tech Stand Neurosurg, 35, pp.159~182 (2010)
24. Buckner JC, "Radiation plus chemotherapy in low-grade glioma", N Engl J Med, 375, pp.490~491 (2016)
25. Shaw EG, "Randomized trial of radiation therapy plus procarbazine, lomustine, and vincristine chemotherapy for supratentorial adult low-grade glioma : initial results of RTOG 9802", J Clin Oncol, 30, pp.3065~3070 (2012)
26. Buckner JC, "Phase II trial of procarbazine, lomustine, and vincristine as initial therapy for patients with low-grade oligodendroglioma or oligoastrocytoma : efficacy and associations with chromosomal abnormalities", J Clin Oncol, 21, pp.251~255 (2003)
27. Stege EM, "Successful treatment of low-grade oligodendroglial tumors with a chemotherapy regimen of procarbazine, lomustine, and vincristine", Cancer, 103, pp.802~809 (2005)
28. Newlands ES, "Temozolomide : a review of its discovery, chemical properties, pre-clinical development and clinical trials", Cancer Treat Rev, 23, pp.35~61 (1997)
29. Stupp R, "Current and future developments in the use of temozolomide for the treatment of brain tumours", Lancet Oncol, 2, pp.552~560 (2001)
30. Stupp R, "Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma", N Engl J Med, 352, pp.987~996 (2005)
31. Tolcher AW, "Marked inactivation of O6-alkylguanine-DNA alkyltransferase activity with protracted temozolomide schedules", Br J Cancer, 88, pp.1004~1011 (2003)
32. Izquierdo C, "Long-term impact of temozolomide on 1p", 19q-codeleted low-grade glioma growth kinetics, 2018, pp.136, 533~539
33. Fisher BJ, "Phase 2 study of temozolomide-based chemoradiation therapy for high-risk low-grade gliomas : preliminary results of Radiation Therapy Oncology Group 0424", Int J Radiat Oncol Biol Phys, 91, pp.497~504 (2015)
34. Wick W, "NOA-04 randomized phase III trial of sequential radiochemotherapy of anaplastic glioma with procarbazine, lomustine, and vincristine or temozolomide", J Clin Oncol, 27, pp.5874~5880 (2009)
35. Chang S, "Phase III randomized study of radiation and temozolomide versus radiation and nitrosourea therapy for anaplastic astrocytoma : results of NRG Oncology RTOG 9813", Neuro Oncol, 19, pp.252~258 (2017)
36. Kesari S, "Phase II study of protracted daily temozolomide for low-grade gliomas in adults", Clin Cancer Res, 15, pp.330~337 (2009)
37. Pouratian N, "Toxicity and efficacy of protracted low dose temozolomide for the treatment of low grade gliomas", J Neurooncol, 82, pp.281~288 (2007)
38. Fan CH, "O6-methylguanine DNA methyltransferase as a promising target for the treatment of temozolomide-resistant gliomas", Cell Death Dis, 4, pp.e876~ (2013)
39. Hoang-Xuan K, "Temozolomide as initial treatment for adults with low-grade oligodendrogliomas or oligoastrocytomas and correlation with chromosome 1p deletions", J Clin Oncol, 22, pp.3133~3138 (2004)
40. Levin N, "Progressive low-grade oligodendrogliomas : response to temozolomide and correlation between genetic profile and O6-methylguanine DNA methyltransferase protein expression", Cancer, 106, pp.1759~1765 (2006)
41. Johnson BE, "Mutational analysis reveals the origin and therapy-driven evolution of recurrent glioma", Science, 343, pp.189~193 (2014)
42. Brada M, "Phase II study of primary temozolomide chemotherapy in patients with WHO grade II gliomas", Ann Oncol, 14, pp.1715~1721 (2003)
43. Baumert BG, "Temozolomide chemotherapy versus radiotherapy in high-risk low-grade glioma(EORTC 22033-26033) : a randomised, open-label, phase 3 intergroup study", Lancet Oncol, 17, pp.1521~1532 (2016)
44. Ruge MI, "Stereotactic iodine-125 brachytherapy for the treatment of WHO grades II and III gliomas located in the central sulcus region", Neuro Oncol, 15, pp.1721~1731 (2013)
45. McCubrey JA, "Mutations and deregulation of Ras", Raf, ERK and PI3K, pp.PTEN, Akt[DOI]
46. Wahl M, "Probing the phosphatidylinositol 3-kinase", mammalian target of rapamycin pathway in gliomas : a phase 2 study of everolimus for recurrent adult low-grade gliomas, 2017, pp.123, 4631~4639
47. Hanaei S, "Therapeutic efficacy of specific immunotherapy for glioma : a systematic review and meta-analysis", Rev Neurosci, 29, pp.443~461 (2018)
48. Kim W, "Dendritic cell vaccines for brain tumors", Neurosurg Clin N Am, 21, pp.139~157 (2010)
49. Ni J, "Tyrosine receptor kinase B is a drug target in astrocytomas", Neuro Oncol, 19, pp.22~30 (2017)
50. Ceccarelli M, "Molecular profiling reveals biologically discrete subsets and pathways of progression in diffuse glioma", Cell, 164, pp.550~563 (2016)

관련 논문AI추천